Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR Fluorescence Imaging with ICG in Head and Neck Cancer
NCT02027831Phase 2Unknown
- Sponsor
- Institut Jules Bordet
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in head and neck cancer (HNC), sponsored by Institut Jules Bordet. Primary endpoint: Evaluation of the capacity of ICG to detect cervical lymph nodes after IV injection at 7 months. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02027831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027831.